1-20 of 35
David Martínez-Cuadrón
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patterns of Salvage Therapy in Patients with Acute Myeloid Leukemia Treated Upfront with Azacitidine or Decitabine: Results from the Pethema AML Registry

Jorge Labrador, Adolfo de la Fuente, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Josefina Serrano, Mar Tormo, Jose Pérez-Simón, Fernando Ramos, Teresa Bernal del Castillo, Maria López-Pavía, Fernanda Trigo, Pilar Martinez Sanchez, Juan Ignacio Rodriguez-Gutierrez, Carlos Rodriguez, Cristina Gil, Daniel Garcia, Susana Vives, Maria Angeles Foncillas, Manuel Perez Encinas, Andrés Novo, Isabel Recio, Gabriela Rodriguez Macias, Juan Miguel Bergua Burgues, Victor Noriega Concepcion, Esperanza Lavilla, Alicia Roldán Pérez, Miguel A. Sanz, Pau Montesinos
Journal: Blood
Blood (2021) 138 (Supplement 1): 1255.
DOI: https://doi.org/10.1182/blood-2021-150544
Published: 2021
Journal Articles

Long-Term Subgroup Analyses from Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry

Jorge Labrador, Adolfo de la Fuente, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Josefina Serrano, Mar Tormo, Jose Pérez-Simón, Fernando Ramos, Teresa Bernal del Castillo, Maria López-Pavía, Fernanda Trigo, Pilar Martinez Sanchez, Juan Ignacio Rodriguez-Gutierrez, Carlos Rodriguez, Cristina Gil, Daniel Garcia, Susana Vives, Maria Angeles Foncillas, Manuel Perez Encinas, Andrés Novo, Isabel Recio, Gabriela Rodriguez Macias, Juan Miguel Bergua Burgues, Victor Noriega Concepcion, Esperanza Lavilla, Alicia Roldán Pérez, Miguel A. Sanz, Pau Montesinos
Journal: Blood
Blood (2021) 138 (Supplement 1): 1256.
DOI: https://doi.org/10.1182/blood-2021-150649
Published: 2021
Journal Articles

Impact of Sociodemographic and Clinical Factors on the Survival of Patients with Acute Myeloid Leukemia: A Multicenter Experience in Colombia, on Behalf of Acho's Renehoc-Pethema Investigators

Claudia Lucia Sossa, Virginia Abello, Angela María Peña, Luis Antonio Salazar, Guillermo Quintero Vega, William Armando Mantilla Duran, Henry Idrobo, Jheremy Enrique Reyes Castellanos, Lina Gaviria, Carlos Daniel Bermudez Silva, Rigoberto Gomez, Mario Ernesto Correa, Paola Guerrero, Jose Sandoval-Sus, David Martínez-Cuadrón, Miguel A. Sanz, Pau Montesinos
Journal: Blood
Blood (2021) 138 (Supplement 1): 3374.
DOI: https://doi.org/10.1182/blood-2021-150930
Published: 2021
Journal Articles

Integrated Multidimensional Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) to Reconstruct Evolutionary Paterns from Dysplasia to Acute Myeloid Leukemia (AML)

Catia Patricia Simoes, Carmen Chillon, David Martínez-Cuadrón, María José Calasanz, María-Belén Vidriales, Iria Vazquez, Montserrat Hernández-Ruano, Beñat Ariceta, Leire Burgos, Diego Alignani, Sarvide Sarai, Sara Villar, Felipe Prósper, Rosa Ayala, Joaquín Martínez-Lopez, Juan Miguel Bergua Burgues, Susana Vives, Jose A. Perez-Simon, María García-Fortes, Marcos González, Jesus San-Miguel, Miguel A. Sanz, Pau Montesinos, Bruno Paiva
Journal: Blood
Blood (2021) 138 (Supplement 1): 520.
DOI: https://doi.org/10.1182/blood-2021-145737
Published: 2021
Journal Articles

Venetoclax Therapy in a Heavily Treated Cohort of Patients with Relapsed or Refractory Acute Myeloid Leukemia: Update of the Pethema Registry Experience

Jorge Labrador, Miriam Saiz-Rodríguez, Maria Dunia De Miguel, Almudena De Laiglesia, Carlos Rodriguez, María Belén Vidriales, Manuel Pérez-Encinas, Maria Jose Sanchez, Rebeca Cuello, Alicia Roldán Pérez, Susana Vives, Gonzalo Benzo Callejo, Mercedes Colorado Araujo, María García-Fortes, Maria Jose Sayas, Carmen Olivier, Isabel Recio, Diego Conde, Alvaro Bienert Garcia, Maria Vahi, Carmen Muñoz García, Cristina Seri, Mar Tormo, Ferran Vall-llovera, Maria Angeles Foncillas, David Martínez-Cuadrón, Miguel A. Sanz, Pau Montesinos
Journal: Blood
Blood (2021) 138 (Supplement 1): 2325.
DOI: https://doi.org/10.1182/blood-2021-150231
Published: 2021
Journal Articles

Long-Term Survival after Intensive Chemotherapy or Hypomethylating Agents in AML Patients Aged 70 Years and Older: A Large Patient Data Set Study from Dataml, SAL and Pethema European Registries

Christian Recher, Christoph Rollig, Emilie Berard, Sarah Bertoli, Pierre-Yves Dumas, Suzanne Tavitian, Hubert Serve, Martin Bornhäuser, Uwe Platzbecker, Carsten Müller-Tidow, Claudia D. Baldus, David Martínez-Cuadrón, Josefina Serrano, Pilar Martínez, Eduardo Rodríguez-Arbolí, Cristina Gil, Juan-Miguel Bergua, Teresa Bernal, Adolfo de la Fuente, Eric Delabesse, Audrey Bidet, Arnaud Pigneux, Pau Montesinos, Michael Kramer
Journal: Blood
Blood (2021) 138 (Supplement 1): 872.
DOI: https://doi.org/10.1182/blood-2021-147735
Published: 2021
Journal Articles

Nationwide Laboratory Network for AML Cross-Validated NGS Studies: Results from a Real-Life Cohort of the Pethema Group

Claudia Sargas, Rosa Ayala, Carmen Chillon, Maria Jose Larrayoz, Estrella Carrillo, Cristina Bilbao, Manuel Yébenes, Marta Llop, Inmaculada Rapado, Ramon Garcia-Sanz, Iria Vazquez, Elena Soria, Santiago Sánchez-Sosa, Kamila Janusz, Carmen Botella, Josefina Serrano, David Martinez-Cuadron, Juan-Miguel Bergua, Maria Luz Amigo, Pilar Martinez Sanchez, Mar Tormo, Teresa Bernal, Pilar Herrera-Puente, Raimundo García-Boyero, Lorenzo Algarra, Maria Jose Sayas, Lisette Costilla-Barriga, Esther Pérez-Santolalla, Inmaculada Marchante, Esperanza Lavilla-Rubira, Víctor Noriega, Juan Manuel Alonso Dominguez, Miguel A. Sanz, Joaquín Sánchez, María Teresa Gómez-Casares, Jose A. Perez-Simon, María José Calasanz, Marcos González, Joaquín Martínez-López, Eva Barragán, Pau Montesinos
Journal: Blood
Blood (2021) 138 (Supplement 1): 1302.
DOI: https://doi.org/10.1182/blood-2021-152353
Published: 2021
Journal Articles

Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4

Sabine Kayser, David Martínez-Cuadrón, Maher Hanoun, Friedrich Stölzel, Cristina Gil, H. Christian Reinhardt, Eliana Aguiar, Kerstin Schäfer-Eckart, Juan Miguel Bergua Burgues, Björn Steffen, Teresa Bernal, Stefan W. Krause, Rosalia Riaza, Christoph Schliemann, Jose Cervera, Martin Kaufmann, Laura Torres, Mathias Haenel, Evelyn Acuña-Cruz, Edgar Jost, Jesús Lorenzo Algarra, Martina Crysandt, Lars Fransecky, Javier Cornago Navascués, Sabrina Kraus, Joaquin Martinez-Lopez, Hermann Einsele, Dirk Niemann, Andreas Neubauer, Ruth Seggewiss-Bernhardt, Sebastian Scholl, Stefan Klein, Christoph Schmid, Markus Schaich, Martin Schmidt-Hieber, Anthony D. Ho, Uwe Platzbecker, Claudia D. Baldus, Carsten Müller-Tidow, Christian Thiede, Martin Bornhäuser, Hubert Serve, Mark Levis, Pau Montesinos, Christoph Röllig, Richard F. Schlenk
Journal: Blood
Blood (2021) 138 (Supplement 1): 1307.
DOI: https://doi.org/10.1182/blood-2021-150281
Published: 2021
Journal Articles

Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the Pethema Registry

Jorge Labrador, David Martínez-Cuadrón, MD, Adolfo de la Fuente, Rebeca Rodríguez-Veiga, MD, Josefina Serrano, MD, Mar Tormo, MD, Jose Antonio Pérez-Simón, MD, Fernando Ramos, Teresa Bernal del Castillo, MD PhD, Maria López-Pavía, Fernanda Trigo, Pilar Martinez Sanchez, Juan Ignacio Rodriguez-Gutierrez, Carlos Rodriguez, Cristina Gil, Daniel Garcia, Susana Vives, MD, Maria Angeles Foncillas, Manuel Perez Encinas, MD, Andrés Novo, MD, Isabel Recio, Gabriela Rodriguez-Macías, MD, Juan Miguel Bergua Burgues, MD, Victor Noriega Concepcion, Esperanza Lavilla, Alicia Roldán Pérez, Miguel A. Sanz, MD, Pau Montesinos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–27.
DOI: https://doi.org/10.1182/blood-2020-141213
Published: 2020
Journal Articles

Impact of Measurable Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC): A Real-World Study in 1,076 Patients with Acute Myeloid Leukemia (AML)

Bruno Paiva, PhD, María Belén Vidriales, Maria Desamparados Sampere Talens, Fabian Tarin, Enrique Colado, Celina Benavente, María Teresa Cedena, MD, Joaquin Sanchez, MD, Teresa Caballero-Velázquez, MD PhD, Lourdes Cordon, David Martínez-Cuadron, MD, Teresa Bernal del Castillo, MD PhD, Carmen Botella, Sofia Grille, MDPhD, Josefina Serrano, MD, Carlos Rodriguez, Jesús Lorenzo Algarra, Juan Manuel Alonso Dominguez, MD PhD MSc, Maria Luz Amigo, MD, Manuel BARRIOS García, MDPhD, Raimundo García-Boyero, MD, Mercedes Colorado, MD, Jaime Perez De Oteyza, MDPhD, Manuel Perez Encinas, MD, Lissette Del Pilar Costilla, MD, Maria Jose Sayas, Olga Pérez-López, Marcos González, Jose A. Perez-Simon, MD PhD, Joaquin Martinez-Lopez, MD PhD, Claudia Lucia Sossa, Alberto Orfao, MD PhD, Jesús F. San-Miguel, Miguel Sanz, MD PhD, Pau Montesinos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–15.
DOI: https://doi.org/10.1182/blood-2020-134349
Published: 2020
Journal Articles

Measurable Residual Disease (MRD) in Elderly Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial

Catia Patricia Simoes, MD, Bruno Paiva, PhD, David Martínez-Cuadron, MD, Juan-Miguel Bergua, MD, Susana Vives, MD, Jesús Lorenzo Algarra, Mar Tormo, MD, Pilar Martinez, MD, Josefina Serrano, MD, Pilar Herrera, MD, Fernando Ramos, MDPhD, Olga Salamero, MD, Esperanza Lavilla, Cristina Gil, Jose Luiz Lopez Lorenzo, MD, Maria-Belen Vidriales, MD, Jorge Labrador, José F. Falantes, Maria Jose Sayas, Rosa Ayala, MD PhD, Joaquin Martinez-Lopez, MD, Sara Villar, María José Calasanz, PhD, Felipe Prosper, MD, Jesús F. San-Miguel, Miguel A. Sanz, Pau Montesinos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32.
DOI: https://doi.org/10.1182/blood-2020-134651
Published: 2020
Journal Articles

Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The Pethema Registry Experience

Jorge Labrador, Miriam Saiz-Rodríguez, Maria Dunia De Miguel, MD, María Belén Vidriales, Manuel Perez Encinas, MD, Maria Jose Sanchez, MD, Rebeca Cuello, MD, Alicia Roldán Pérez, Susana Vives, MD, Gonzalo Benzo Callejo, Mercedes Colorado Araujo, María García-Fortes, Maria Jose Sayas, Carmen Olivier, Isabel Recio, Diego Conde Royo, Alvaro Bienert Garcia, MD, Maria Vahi, Carmen Muñoz García, PhD, Cristina Seri, MD, Mar Tormo, MD, Ferran Vall-llovera, Maria Angeles Foncillas, David Martínez-Cuadron, MD, Miguel A. Sanz, MD, Pau Montesinos, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
DOI: https://doi.org/10.1182/blood-2020-141191
Published: 2020
Journal Articles

Comparison of Azacitidine and Decitabine for the Treatment of Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Miriam Saiz-Rodríguez, Beatriz Cuevas, MD PhD, David Martínez-Cuadrón, MD, Verónica Campuzano, Maria Victoria Cuevas, Gerardo Hermida, Rodolfo Alvarez, Tomás José González-López, MD, Francisco Javier Diaz-Galvez, Raquel Alcaraz, Pilar de Vicente, Miguel A. Sanz, MD, Pau Montesinos, MD PhD, Jorge Labrador
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
DOI: https://doi.org/10.1182/blood-2020-141539
Published: 2020
Journal Articles

Outcomes after Plerixafor Plus FLAG-IDA (PLERIFLAG) Versus FLAG-IDA +/- Gentuzumab for Adult Patients with First Relapsed/Refractory AML: A Propensity Score Analysis from the Pethema Registry

Juan Miguel M. Bergua Burgues, Isabel Cano-Ferri, Cano-Ferri, David Martínez-Cuadron, MD, Blanca Boluda, Pilar Martínez-Sánchez, Rebeca Rodríguez-Veiga, MD, Jordi Esteve, Susana Vives, MD, Josefina Serrano, Maria-Belen Vidriales, MD, Olga Salamero, MD, Carlos Carretero, Ana Jimenez-Ubieto, Ignacio Casas, MD, Rocio Cardesa, MD, Marina Diaz-Beyá, MD, Salut Brunet, MD PhD, Celina Benavente, Jose Antonio Pérez-Simón, Federico Moscardo, MD, Eliana Aguiar, Manuel Perez Encinas, MD, Aurelio López Martínez, MD, Carlos Rguez, A. Cabello, MD, Jorge Labrador, Lissette Del Pilar Costilla, MD, Claudia Sossa, MD, Teresa Bernal Del Castillo, MD PhD, Miguel A. Sanz, Pau Montesinos, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1321.
DOI: https://doi.org/10.1182/blood-2019-128568
Published: 2019
Journal Articles

Mutational Profiling Predicts Clinical Outcomes to Azacytidine and Low Dose Cytarabine Plus Fludarabine (FLUGA) in Elderly Acute Myeloid Leukemia Patients Enrolled in the Pethema Phase III Flugaza Trial

Rosa M. Ayala, MD PhD, Inmaculada Rapado, David Martínez-Cuadron, MD, Esther Onecha, PhD, Laura Rufian, Miss, Alexandra Juarez, Juan Bergua Burgues, Susana Vives, MD, Jesús Lorenzo Algarra, Mar Tormo, MD PhD, Pilar Martinez, MD, Josefina Serrano, Pilar Herrera, MD, Fernando Ramos, Olga Salamero, MD, Esperanza Lavilla, Cristina Gil, MD, Jose Luis Lopez Lorenzo, MD, Maria-Belen Vidriales, MD, Jorge Labrador, MD, José F. Falantes, Maria Jose Sayas, Bruno Paiva, PhD, Eva Barragán, Felipe Prosper, MD PhD, Miguel A. Sanz, Joaquin Martinez Lopez, MD PhD, Pau Montesinos Fernandez, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3891.
DOI: https://doi.org/10.1182/blood-2019-127187
Published: 2019
Journal Articles

A Predictive Model for Early Death after Frontline Hypomethylating Agents in Elderly Unfit Acute Myeloid Leukemia Patients: Results from the Pethema Group

Fernando Ramos, David Martinez-Cuadron, Josefina Serrano, Maria Lopez-Pavia, Marta Fuertes-Nuñez, Teresa Bernal, Juan Ignacio Rodriguez-Gutierrez, Isabel Recio, Ana Garrido, Daniel Garcia, Claudia Lucia Sossa, MD, Cristina Gil, Rosario Varela, Pilar Martinez-Sanchez, Maria Angeles Foncillas, Mar Tormo, Antonia Cladera, Graca Esteves, José F. Falantes, Adolfo de la Fuente, Blanca Boluda, Miguel A. Sanz, Pau Montesinos Fernandez, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 648.
DOI: https://doi.org/10.1182/blood-2019-125053
Published: 2019
Journal Articles

Precision Medicine Test Is Similar but Faster Than Conventional Cytogenetics Predicting Response in AML Patients and Provides Alternative Treatments

Joan Ballesteros, PhD, David Martínez-Cuadron, MD, Joaquin Martinez Lopez, MD PhD, Juan Miguel Miguel Bergua Burgues, Mar Tormo, MD PhD, Josefina Serrano, MD, Ataulfo González, MD, Jaime Perez De Oteyza, MDPhD, Susana Vives, MD, Maria-Belen Vidriales, MD, Pilar Herrera, MD, Juan Antonio Vera, MD, Aurelio Lopez Martinez, MD, Adolfo de la Fuente, MD, Lourdes Amador Barciela, MD, Jose Angel Hernandez-Rivas, MD, Maria Angeles Fernandez Fernandez, MD, Carlos Cervero, MD, Daniel Morillo, MD, Pilar Hernandez, PhD, Daniel Primo, PhD, Julian Gorrochategui, Jose Luis Rojas, Iñaki Troconiz, PhD, Jesús Villoria, Miguel Sanz, Pau Montesinos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1493.
DOI: https://doi.org/10.1182/blood-2018-99-115849
Published: 2018
Journal Articles

Role of Measurable Residual Disease (MRD) in Redefining Complete Response (CR) in Elderly Patients with Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial

Bruno Paiva, MD PhD, David Martínez-Cuadron, MD, Juan Miguel Miguel Bergua Burgues, Susana Vives, MD, Jesús Lorenzo Algarra, Mar Tormo, MD PhD, Pilar Martínez-Sánchez, MD, Josefina Serrano, MD, Pilar Herrera, MD, Fernando Ramos, Olga Salamero, MD, Esperanza Lavilla, Cristina Gil, MD, Jose Luiz Lopez Lorenzo, MD, Maria-Belen Vidriales, MD, Jorge Labrador, MD, José F. Falantes, MD, Maria Jose Sayas, Juana Merino, Ana Alfonso, MD, Felipe Prosper, MD PhD, Jesus F San-Miguel, MD PhD, Miguel A. Sanz, MD, Pau Montesinos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 433.
DOI: https://doi.org/10.1182/blood-2018-99-113299
Published: 2018
Journal Articles

Characteristics and Outcome of Older Patients with Acute Promyelocytic Leukemia Front-Line Treated with or without Arsenic Trioxide — an International Collaborative Study

Sabine Kayser, MD, Ramy Rahmé, David Martínez-Cuadron, MD, Gabriel Ghiaur, MD PhD, Xavier Thomas, MD, Marta Sobas, MD, Agnes Guerci Bresler, Salut Brunet, MD PhD, Arnaud Pigneux, MD PhD, Cristina Gil, MD, Emmanuel Raffoux, Mar Tormo, MD PhD, Norbert Vey, MD PhD, Javier de la Serna, MD, Olga Salamero, MD, Eva Lengfelder, MD, Mark J. Levis, MD, Pierre Fenaux, MD PhD, Miguel A. Sanz, MD, Richard F. Schlenk, MD, Uwe Platzbecker, Lionel Ades, MD PhD, Pau Montesinos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 80.
DOI: https://doi.org/10.1182/blood-2018-99-111768
Published: 2018
Journal Articles

Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An Analysis from a Large International Patient Cohort

Maximilian Stahl, MD, Wei Wei, MD PhD, Pau Montesinos, MD PhD, Etienne Lengline, MD, Rory M Shallis, MD, Judith Neukirchen, MD, Vijaya R. Bhatt, MD, Mikkael A. Sekeres, MD MS, Amir T. Fathi, MD, Heiko Konig, MDPhD, Selina Luger, MD, Irum Khan, MBBS, Gail J. Roboz, MD, Thomas Cluzeau, MD PhD, David Martínez-Cuadron, MD, Emmanuel Raffoux, MD, Ulrich Germing, MD, Jayadev Manikkam Umakanthan, MBBS, Sudipto Mukherjee, MD PhD MPH, Andrew M. Brunner, MD, Adam M. Miller, BS, MD, Christine M. McMahon, MD, Ellen K. Ritchie, MD, Rebeca Rodríguez-Veiga, MD, Raphael Itzykson, MD PhD, Blanca Boluda, MD, Florence Rabian, MD, Mar Tormo, MD, Evelyn Gloria Acuna Cruz, MD, Emma Rabinovich, MD, Brendan Yoo, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Amer M. Zeidan, MBBS, MHS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1428.
DOI: https://doi.org/10.1182/blood-2018-99-112495
Published: 2018